NEO:NASDAQ
NeoGenomics, Inc.
၉.၀၀ US$
arrow_downward
-၄.၆၆%(-၀.၄၄) 1D
၉.၀၀ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: မေ ၄, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEO...
Open
၉.၃၇ US$
High
၉.၇၀ US$
Low
၈.၉၉ US$
Mkt. cap
၁၁၇.၁၉ ဋေ
Avg. vol.
၂.၃၆ သန်း
Volume
၀.၀၀
52-wk high
၁၃.၇၄ US$
52-wk low
၄.၇၂ US$
EPS
-၀.၇၇ US$
Beta
၁.၈၁
Shares outstanding
၁၃.၀၂ ကုဋေ
No. of employees
၂ ထောင်
News stories
From sources across the web
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
About NeoGenomics, Inc.
CEOChristopher M. Smith
Employees၂.၅ ထောင်
Founded၂၀၀၂
Headquartersဖေါ့တ်မိုင်ရာစ်, ဖလော်ရီဒါပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth care provider
Websiteneogenomics.com
AI content may include mistakes. Learn more